Press Releases

Sep 15, 2016

PharmaCyte’s CEO Discusses Development of its Pancreatic Cancer Therapy

Sep 1, 2016

PharmaCyte Biotech Reports on Progress in Its Medical Cannabis Program

Aug 2, 2016

Dr. Mark L. Rabe Presents PharmaCyte Biotech’s Ongoing Research at Cannabis Cancer Forum

Jul 29, 2016

PharmaCyte Biotech Releases Shareholder Call Playback Information

Jul 25, 2016

PharmaCyte Biotech Shareholder Call Update

Jul 19, 2016

As Diabetes Becomes Global Epidemic, PharmaCyte Biotech's Insulin Producing Cells Receive 20 Years of Protection

Jul 14, 2016

PharmaCyte Biotech Receives Patent Protection of the Melligen Cells to Treat Diabetes

Jul 11, 2016

PharmaCyte Biotech to Hold Shareholder Call

Jul 7, 2016

PharmaCyte Biotech Uses "Artificial Liver" to Treat Advanced Pancreatic Cancer

Jul 5, 2016

PharmaCyte’s Research on Medical Uses of Cannabinoids Supported by Recent Scientific Article